Protalix BioTherapeutics
PLX
#8971
Rank
NZ$0.32 B
Marketcap
NZ$4.02
Share price
-2.92%
Change (1 day)
60.22%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2026 (TTM): NZ$0.36

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.36. In 2025 the company made an earnings per share (EPS) of NZ-$0.14 a decrease over its 2024 EPS that were of NZ$0.06909.

EPS history for Protalix BioTherapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.36-362.83%
2025NZ-$0.14-300%
2024NZ$0.06909-66.67%
2023NZ$0.21-138.71%
2022NZ-$0.54-50%
2021NZ-$1.07181.82%
2020NZ-$0.38-82.11%
2019NZ-$2.12-31.67%
2018NZ-$3.11-72.31%
2017NZ-$11.23124.14%
2016NZ-$5.01-147.54%
2015NZ$10.54-290.62%
2014NZ-$5.536.67%
2013NZ-$5.18130.77%
2012NZ-$2.25-69.77%
2011NZ-$7.4319.44%
2010NZ-$6.22-12.2%
2009NZ-$7.0836.67%
2008NZ-$5.18-37.5%
2007NZ-$8.2950%
2006NZ-$5.533.23%
2005NZ-$5.35138.46%
2004NZ-$2.25-74%
2003NZ-$8.64-0%
2002NZ-$8.64-50%
2001NZ-$17.27233.33%
2000NZ-$5.18-84.21%
1999NZ-$32.82-24%
1998NZ-$43.18-600%
1997NZ$8.64-16.67%
1996NZ$10.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.26 523.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$11.59 3,095.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ-$0.19-152.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.37 552.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel